Main Menu
Login
Related Links
More news sources
News Submission
Special News Items
- Avexis Receives FDA Approval For Zolgensma, First And Only Gene Therapy For Pediatric Patients With Spinal Muscular Atrophy
- NIH Streamlines Gene Therapy Oversight and Charts a Course for Considering Emerging Technology
- Novartis Says Baby's Death May Be Tied to Gene Therapy
- First gene therapy to treat rare blood disease nears European approval
- Should gene therapy patients be asked to pay?
- New Gene Therapy Shows Promise For Patients With Sickle Cell Disease
- Gene Therapy Drug Approval to Skyrocket by 2025
- Gene therapy for Crigler-Najjar syndrome - First patient treated in the European clinical trial
- Chinese Researchers Claim to Have Genetically Engineered the First HIV-Immune Babies
- Spark Therapeutics' Luxturna Gets EU Approval for Vision Loss
- Gene therapy drugs step toward approval in Japan
- Infectivity of adeno-associated virus serotypes in mouse testis
- FDA Lifts Clinical Hold; Green-Lights Vertex and CRISPR’s Sickle Cell Gene Therapy Trial
- Screening Clinical Cell Products for Replication Competent Retrovirus: The National Gene Vector Biorepository Experience
- European Commission Approves Novartis’ Kymriah CAR-T Cell Therapy
- Health Officials Remove Special NIH Oversite Rules Governing Gene Therapy Experiments
- FDA Seeks to Enhance Manufacturing of Cell and Gene Therapies
- New EU initiatives to optimize the interplay between the Pharma and the GMO framework
- Caution required for using CRISPR/Cas9 in potential gene therapies
- First cohort enrolled in trial with innovative gene therapy for arthritis